Jakob Cramer

Dr Jakob Peter Cramer is a medical doctor specialised in internal medicine, tropical medicine, travel medicine and infectious diseases. He joined the Coalition for Epidemic Preparedness Innovations (CEPI) as Director of Clinical Development in June 2019. Prior to his role at CEPI, Jakob was Head of the Tropical Medicine Section at the University Medical Center Hamburg-Eppendorf as well as the Clinical Research Unit at the Bernhard Nocht Institute for Tropical Medicine (BNITM) in Hamburg, Germany, where he founded the clinical trials unit and conducted Phase 1/2/3 vaccine trials against various infectious diseases (including influenza, rabies, Japanese encephalitis, meningococcal diseases, travellers’ diarrhoea). During his 14 years in academia, he engaged in epidemiological and investigator-initiated clinical research in Africa. From 2014 to 2019, Jakob held the position of Medical Director, Clinical Development, Vaccine Business Unit, Takeda Pharmaceuticals International AG, Zurich, Switzerland where he was actively involved in Takeda’s norovirus and dengue as well as the BMGF-funded polio vaccine development programmes. He is a lecturer at various courses in the fields of vaccinology and infectious diseases. He is also a member of a number of infectious diseases societies.